Rob. Thanks,
came XX% the organic our revenue which million, Let's XXX of EBITDA software and margin. segment. turn XXX and and was to represented represented the go which our revenues in plus to million, XX.X% In at was application segment quarter,
Starting we've we with trends the several that discussed Deltek, over few continuation quarters. a of past a saw
First, offerings. we saw of an acceleration in mix an bookings revenues and result recurring of SaaS a towards increased Deltek as business
In contract. fact, largest in their SaaS the quarter, Vantagepoint's Deltek signed
is enterprise As offering Deltek's a new reminder, targeting service professionals Vantagepoint firms. software
Deltek a volume execute year comp of see to given Adjusting continues team well. a a services ago. signed a digits very two end business their government continues Deltek you, bookings perpetual this, exceptionally the markets, deal grew and for the their balance activity across remind macro nice to contract. had difficult To large of Deltek in very double professional Also, quarter.
Aderant of law experienced share a the in gains newer result growth, as firm. continued adoption of double-digit solutions targeting staff their
we've Aderant’s several the over quarters. note, highlighted may strength last competitive you As
and time to XXXX, competitively of competitor, added approximately period XX,XXX team XX,XXX core that job. Deane which their do their Over and have done since won has her largest been timekeepers a to roughly from at Aderant continue and great have of platform, Aderant
revenues expanding strong customer nice saw PowerPlan, we retention in At recurring rates base. an based continued and on increases
to is revenues following systematically license accounting ads sales the aggressively driven and Importantly, important standards. new and This of increase following working the lease their particularly is implementation the regulatory new increase funnel. PowerPlan team volume the pipeline and
again increases cash nice saw we CBORD at with performance. excellent Also,
our solutions CBORD that care and integrated reminder, to software education business a campuses. is higher security As health delivers and payment
cost for Finally, based continued their products new Strata market log quarter for adoption gains and activity, great another the share Support strong products Decision renewal accounting very on SaaS of market. their hospital and
outlook for we X% comps expect half the slightly to The be in in to the second organic for we X% expect the the to versus for continue we segment's the organic and As QX. of QX better turn normalize half, that will increases segment. second Deltek growth to
slide. Next
Systems revenue XX% which basis. million, segment. turning our XX.X%. $XXX of segment a and million organic Roper’s plus Network an was of This Software System, was X% the in And on represented was EBITDA quarter represented $XXX to margin revenue revenue which &
match offering. the by both and strength demand The quarter markets. rates at our saw particular, U.S. Canadian In freight and businesses, our for growth highlighted data we was of continued
remind performance new for non-hospital continues pharmacy, position long-term the marketplaces. share the is The trends. care quarter of the MHA’s care several home of pharmacies. facilities MHA team long-term the to by To leadership and in market group network was purchasing strong on-boarding with infusion market, to largest highlighted win relative and everyone, and gain started
new good here, nothing go-to team. by a the So, market job and
in started see contract. food the customer MHA nicely just into increased due benefits and to to the the pricing Importantly being the range. on pharmaceutical new businesses of grew and quarter stabilize products appears quarter, several mid-single-digit purchasing portfolio Also, nutrition in volumes
business a very a had an our Automation a with Pharmacy and business, This of financial continuing SoftWriters network and software trend. network example benefits. is Software Workflow effects quarter Additionally, nice wonderful
that the products, submission The of the deploys electronic as This core day-to-day develops software automation revenue they use is this and operations. business pharmacy non-retail closed specifically and are or unlocked cross-sell their business that our and door economics in pharmacies customers for recurring a transactional workflow e-prescription. claims
model So, as a pace this business the Nice in job more to expands the as Pittsburgh. recurring more rapid accounts, their the by at customer accelerate. pharmacies team revenues adds economic more and
partner high on in growth. in an strong trading single based grew digits activity and quarter renewal the iTrade increase
customer has contracts worked team recent to the Over iTrade of benefits or increases the quarter. their from last and structure couple their benefits from and the the trading of model iTrade in volume business this we saw years, partners most at
strength for RF on sign-on core a we the secure of adoption based fact The Again, reader business. quarter at record secure is and print strength Ideas, in technology saw marketplaces. RF in continued the Ideas
and an for by and was integrated and the very considering potential partnership evaluating Roper Gentex quarter or other example innovation new is another mirrors business. early by electric Audi's the this toll SUV. At technology release. technology marked of timetable rearview TransCore’s Currently product new proprietary with is exciting OEMs great in released adoption, are a TransCore,
discuss Foundry. And recent We closed the outlook before to quarter. our the during the acquisition, we wanted for we most briefly second segment, the transaction to return
onboard had do governance the and team to and model the Soon after, framework. our introduction CRI we our normal opportunity to
Also, well Foundry. specific as visual long for is of perfectly history that previously in her as this Foundry’s given the Jody with Product we're excited to history Head role, suited industry, named Madden, CEO. her as effects our announce was Jody
has easy far, been transition. So a it very
to able large our days team. to was Jody and new welcome Jody Congrats very in prospects successfully role. planned to a Foundry leadership couple customer close transactions Importantly, with entire early the of of
turning Now to our outlook.
For growth this project new of half, as wins continue segment. the project X% for Role usual see it's to although implementation the pipeline remains and X% we of timing new difficult second robust, TransCore, forecast organic to the to timetable.
slide. Next
segment the is Our Analytical the organic Systems represented at quarter segment and on came an basis, a in XX.X% Measurement for X% of $XXX XX% Roper’s margin. million EBITDA which represented was which Revenue million, and revenue. in $XXX plus
quarter. in American Neptune help had in gain to rooted product record the and continues Neptune intimacy customer innovation market is another North Neptune share strategy systematically market.
had NDI great another quarter.
several is by This and applications. and to optical rooted quarter Waterloo OEMs electromagnetic a in team used in measurement in continue surgical strength do terrific systems NDI's his job. Dave
demand Verathon our increases generation in consumables led glide systems. next for the scan was bladder by Growth and scope recurring revenue
The forward Verathon past site the is seeing September years. for progress to made at Roper Board upcoming of the and Directors the during looking company all has board couple the visit meeting a
and execution Our in a products levels aid of extremely property very quarter that located had City control their assisted high business CIVCO doctors Imaging Multi-Modality ultrasound procedures. ultrasound guidance strong highlighted in was our nice and markets. intellectual ultrasound CIVCO's meaningfully and guidance have Iowa by infection MMI
most infection innovation Our CIVCO's regarding particular recent control. is interest
leader providing For many years, has assisted guided surgical image biopsies. market ultrasound procedures, for a in covers namely CIVCO been
of appears of CIVCO factors team problem. risk for ultrasound that the to solved the smart of conductivity. the that procedures. does risk procedures One Well, an ultrasound protected cross is this have is guided IP gel the gel in They of created the require these used solution contamination ever first at not
with look become we of in product this Europe, to the and is and to team the working team North on standard congrats to make the team its innovation. just the forward launching care. And The American
the Our businesses quarter, a due quarter segment’s push revenues businesses, outs consumable are destocking. in of the project of the by Strewers of down over industrial second are a really about short mid-single all impacted industrial which and digits. to half cycle slowdown late in from XX% and [ph] this pause
high down As such, the bookings in for were group quarter. this single digits
job group this managing Importantly, nice in very did the margins cash and a quarter. flow
terminated quarter the sell has declined have been as Gatan in And we as the expected. concerns. we agreement Thermo regulatory over the to announced,
the for for X% increasing guidance half, turn see segment. we to As the second X% to we organic revenues the
revenues mid-single products are are digit medical the for expected XX% balance increase year. the of segments the Our plus businesses of to roughly which Neptune and
again For business of a cycle shorter industrial revenues. segments XX% the
be high year. half to the second businesses these assumes of the digits single quarter expect down late continues year. the slowdown We industrial balance second for This the for of the
Gatan terminated and was for Thermo in given And sale the the quarter. Gatan of
We have our second Gatan half year included full guidance. now in and
to of the decline modest record expect organic Specifically, the second Also, Gatan we’ve to added $X.XX be given we DEPS XXXX approximately for comps. half.
we have Finally, Gatan. for a sale process reengaged
While early process very exceptional many good from an in with management strong we a team. the received Gatan relaunch interest business is parties.
for Saunders not investing and if long-term look We’re Gatan offers, forward with to completing its receive the owning engaging [ph] economic over with committed we we to but team Gatan do his compelling contractual the and and sale success. process long-term,
Next page.
technology to was was million quarter, a we X% our process in amazing Roper's basis. down represented the an revenue, As which revenue represented $XXX which on segment EBITDA XX.X% $XX the of million, segments turn margin. organic was XX%
year Our That gas in upstream quarter in oil executed across said, comp and points has businesses the outstanding declined from plus EBITDA segment. very a a XXX ago. quarter. were margins the very drove expected margins which nimbly up challenging the the against as was basis XX% business and
continue see into product of to pipeline. CCC, we our Role LNG strength
their Finally, end strong controls demand delivered and quarter Metrix monitoring record based multiple on systems a for markets. across vibration
organic year minus do segment the versus X% see Turning comps X% growth and the for the easing outlook. QX. to We QX of the balance in for see to
to may As upside we higher based in our outlook or on going exist have happen we capacity and prices, but the the potential expanded not have for discussed, this half. takeaway for oil assumed second is
Now update. let’s turn to our guidance
our guidance prior $XX. compared range expect our to range primarily to to to This guidance updating to to $XX.XX approximately our add which a we to of DEPS. the inclusion half second of to We’re $XX.XX DEPS guidance Gatan, relate $X.XXX $XX.XX increase of
a around dynamics Gatan’s the there normal variability Given to the process, expect than greater do we divestiture in half results. be second
a and industrial the may organic continues do our second occurs. cycle leaders soft the not trends the importantly, late that assume guidance pause bounce while patch, not of want we for into we our DEPS business Our businesses. saw be half visibility the just short second assume half more remainder in growth for that year. to do we industrial have back a recovery And the recent
and Accordingly, our focus we and our for lowering revenue assumptions to are businesses continuing high those on expect to flow. cash margin industrial business deliver strong leaders
guidance improve, prove trends industrial Should those businesses our could for conservative.
As it to the X% roughly this enterprise basis. on majority from approximately our our strong of call, remarks clear have continues an of the should XX% growing momentum, on content organic be vast
guidance finally, to rate, the we be rates for adjusted up QX Rolled in our tax our to assume to of DEPS XX%. second approximately And the half X.XX range X.XX. to establishing we’re the be
saw flow We across XX% enterprise. X%, margins the grew execution expanded, cash EBITDA increased the QX and to and turn the quarter. summary. free Now great performance in let’s cash
our continue scale term platform Importantly, models for to discipline to long improvement systematic business provide a growth. CRI
to capital Now deployment. turning
source as very for deployment First balance will be and leverage two the times well-positioned cash our our trailing With excellent primary capital is offensive. performance EBITDA, approaching continue. sheet our to funding,
position better flow to of be BAAX nice able the to Moody’s extent we’re plus for the the complete sale it even is to BBB and we ratings S&P bond. will Gatan, also compound, a cash our upgrade, successfully the a sustained Through accelerate see
maturing to our the outlook pipeline a remain active opportunities the for assets. we We’ll in very of are to always number but very high-quality pipeline. number continue see very in we a and patient, of large commentary, Rolled acquisitions
good Importantly, it’s us and that to orientation acquisition CRI very and M&A everyone the ideas. best on processes our help always remind identify execute
market coaching great to Now on do remind the provide like and strategy, development. relative as running to We flow. industry. We Socratic our niche that that leaders incent simple. based about is compound we talent management innovation and businesses of turn leading with growth. to want operations, portfolio have business cash teams We questions, position looks operating what I we By a everyone very
mutual We free excess powerful simple cash have our These culture to finally, results. and buy better and it take and existing returns than ideas we deploy a transparency of trust flow businesses that our cash company. deliver have
go it and Now questions. over turn let's to the
